CN1297448A - 帕罗西汀抗坏血酸盐 - Google Patents
帕罗西汀抗坏血酸盐 Download PDFInfo
- Publication number
- CN1297448A CN1297448A CN99805160A CN99805160A CN1297448A CN 1297448 A CN1297448 A CN 1297448A CN 99805160 A CN99805160 A CN 99805160A CN 99805160 A CN99805160 A CN 99805160A CN 1297448 A CN1297448 A CN 1297448A
- Authority
- CN
- China
- Prior art keywords
- paroxetine
- compound
- ascorbate
- solution
- paroxetine ascorbate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9808896.6 | 1998-04-25 | ||
| GBGB9808896.6A GB9808896D0 (en) | 1998-04-25 | 1998-04-25 | Novel compound |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1297448A true CN1297448A (zh) | 2001-05-30 |
Family
ID=10831008
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN99805160A Pending CN1297448A (zh) | 1998-04-25 | 1999-04-23 | 帕罗西汀抗坏血酸盐 |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP1089995A1 (sk) |
| JP (1) | JP2002513019A (sk) |
| KR (1) | KR20010042977A (sk) |
| CN (1) | CN1297448A (sk) |
| AP (1) | AP2000001963A0 (sk) |
| AU (1) | AU3618499A (sk) |
| BG (1) | BG104940A (sk) |
| BR (1) | BR9909868A (sk) |
| CA (1) | CA2330055A1 (sk) |
| EA (1) | EA200001104A1 (sk) |
| GB (1) | GB9808896D0 (sk) |
| HU (1) | HUP0102116A3 (sk) |
| ID (2) | ID26654A (sk) |
| IL (1) | IL139081A0 (sk) |
| NO (1) | NO20005352D0 (sk) |
| PL (1) | PL343677A1 (sk) |
| SK (1) | SK15912000A3 (sk) |
| TR (1) | TR200003084T2 (sk) |
| WO (1) | WO1999055698A1 (sk) |
| ZA (1) | ZA200005912B (sk) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110607553A (zh) * | 2018-10-30 | 2019-12-24 | 中国科学院化学研究所 | 一种制备粒径可调的药物或药物中间体单晶或无定型物的方法 |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0003232D0 (en) * | 2000-02-11 | 2000-04-05 | Smithkline Beecham Plc | Novel composition |
| IL159280A0 (en) * | 2001-06-14 | 2004-06-01 | Teva Pharma | A process for preparing paroxetine hcl which limits formation of pink colored compounds |
| CA2471144C (en) | 2002-01-09 | 2011-06-07 | Emisphere Technologies, Inc. | Polymorphs of sodium 4-[(4-chloro-2-hydroxybenzoyl)amino]butanoate |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1422263A (en) * | 1973-01-30 | 1976-01-21 | Ferrosan As | 4-phenyl-piperidine compounds |
| ES2058061T3 (es) * | 1985-10-25 | 1994-11-01 | Beecham Group Plc | Derivado de piperidina, su preparacion y su uso como medicamento. |
| US5276042A (en) * | 1993-04-16 | 1994-01-04 | Crenshaw Roger T | Treatment of premature ejaculation |
| ES2117557B1 (es) * | 1996-02-29 | 1999-07-01 | Ferrer Int | Nuevo procedimiento de obtencion de (-)-trans -n-p-fluorobenzoilmetil-4-(p-fluorofenil)-3- ((3,4-(metilendioxi)fenoxi ) metil)-piperidina. |
-
1998
- 1998-04-25 GB GBGB9808896.6A patent/GB9808896D0/en not_active Ceased
-
1999
- 1999-04-23 CA CA002330055A patent/CA2330055A1/en not_active Abandoned
- 1999-04-23 AP APAP/P/2000/001963A patent/AP2000001963A0/en unknown
- 1999-04-23 ID IDW20002169A patent/ID26654A/id unknown
- 1999-04-23 JP JP2000545858A patent/JP2002513019A/ja active Pending
- 1999-04-23 EP EP99918151A patent/EP1089995A1/en not_active Withdrawn
- 1999-04-23 KR KR1020007011809A patent/KR20010042977A/ko not_active Application Discontinuation
- 1999-04-23 HU HU0102116A patent/HUP0102116A3/hu unknown
- 1999-04-23 ID IDW20002168A patent/ID26083A/id unknown
- 1999-04-23 BR BR9909868-7A patent/BR9909868A/pt not_active Application Discontinuation
- 1999-04-23 PL PL99343677A patent/PL343677A1/xx not_active Application Discontinuation
- 1999-04-23 EA EA200001104A patent/EA200001104A1/ru unknown
- 1999-04-23 AU AU36184/99A patent/AU3618499A/en not_active Abandoned
- 1999-04-23 SK SK1591-2000A patent/SK15912000A3/sk unknown
- 1999-04-23 TR TR2000/03084T patent/TR200003084T2/xx unknown
- 1999-04-23 IL IL13908199A patent/IL139081A0/xx unknown
- 1999-04-23 WO PCT/GB1999/001244 patent/WO1999055698A1/en not_active Application Discontinuation
- 1999-04-23 CN CN99805160A patent/CN1297448A/zh active Pending
-
2000
- 2000-10-23 ZA ZA200005912A patent/ZA200005912B/en unknown
- 2000-10-24 NO NO20005352A patent/NO20005352D0/no not_active Application Discontinuation
- 2000-11-13 BG BG104940A patent/BG104940A/bg unknown
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110607553A (zh) * | 2018-10-30 | 2019-12-24 | 中国科学院化学研究所 | 一种制备粒径可调的药物或药物中间体单晶或无定型物的方法 |
| CN110607554A (zh) * | 2018-10-30 | 2019-12-24 | 中国科学院化学研究所 | 一种制备药物或药物中间体单晶或无定型物的方法 |
| CN110607553B (zh) * | 2018-10-30 | 2024-03-22 | 中国科学院化学研究所 | 一种制备粒径可调的药物或药物中间体单晶或无定型物的方法 |
| CN110607554B (zh) * | 2018-10-30 | 2024-03-22 | 中国科学院化学研究所 | 一种制备药物或药物中间体单晶或无定型物的方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| WO1999055698A1 (en) | 1999-11-04 |
| HUP0102116A3 (en) | 2002-12-28 |
| PL343677A1 (en) | 2001-08-27 |
| SK15912000A3 (sk) | 2001-04-09 |
| GB9808896D0 (en) | 1998-06-24 |
| JP2002513019A (ja) | 2002-05-08 |
| EA200001104A1 (ru) | 2001-04-23 |
| EP1089995A1 (en) | 2001-04-11 |
| IL139081A0 (en) | 2001-11-25 |
| ID26083A (id) | 2000-11-23 |
| HUP0102116A2 (hu) | 2002-05-29 |
| ZA200005912B (en) | 2001-12-19 |
| TR200003084T2 (tr) | 2001-02-21 |
| NO20005352L (no) | 2000-10-24 |
| BG104940A (bg) | 2001-09-28 |
| AU3618499A (en) | 1999-11-16 |
| NO20005352D0 (no) | 2000-10-24 |
| BR9909868A (pt) | 2000-12-19 |
| KR20010042977A (ko) | 2001-05-25 |
| AP2000001963A0 (en) | 2000-12-31 |
| CA2330055A1 (en) | 1999-11-04 |
| ID26654A (id) | 2001-01-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100514264B1 (ko) | 피페리디노알칸올-충혈완화제 조합용 제약 조성물 | |
| AU2011201520B2 (en) | Capsule Formulation Of Pirfenidone And Pharmaceutically Acceptable Excipients | |
| CA1327011C (en) | Pharmaceutical compositions for piperidino alkanol-ibuprofen combination | |
| US20040242506A1 (en) | Paroxetine glycyrrhizinate | |
| WO1999052931A1 (fr) | Dispersion solide contenant un derive d'acide sialique | |
| CN1297448A (zh) | 帕罗西汀抗坏血酸盐 | |
| EP0310999B1 (en) | Pharmaceutical composition for piperidinoalkanol derivatives | |
| SK286040B6 (sk) | Farmaceutická kompozícia obsahujúca 1-(2-naft-2-yletyl)-4-(3- trifluórmetylfenyl)-1,2,3,6-tetrahydropyridín hydrochlorid a donepezil alebo takrín | |
| CN101541769A (zh) | 地拉罗司(deferasirox)(icl670a)的多晶型物 | |
| CN1189156A (zh) | 作为白三烯拮抗剂的含有二醇的喹啉衍生物 | |
| JPS62190126A (ja) | ジフルニザ−ルとトロメタミンの混合組成物 | |
| WO1999055699A1 (en) | Paroxetine 10-camphorsulfonate for treatment of cns disorders | |
| WO2001014369A2 (en) | Process for the preparation of paroxetin.hcl | |
| MXPA99011699A (en) | Pharmaceutical composition for combination of piperidinoalkanol-decongestant | |
| MXPA00010439A (en) | Paroxetine ascorbate | |
| MXPA00010435A (en) | Paroxetine 10-camphorsulfonate for treatment of cns disorders |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |